DRW Holdings »

Cadrenal Therapeutics shares owned by DRW Holdings

Quarter-by-quarter ownership of Cadrenal Therapeutics (CVKD) shares owned by DRW Holdings from 13F filings

Historical chart of DRW Holdings investment in Cadrenal Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cadrenal Therapeutics held by DRW Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cadrenal Therapeutics by DRW Holdings

Quarter filed Position value Share count Share price at filing
2025-12-31 $171k 25k 6.78

More positions owned by DRW Holdings

iShares Russell 2000 Index Call Option (IWM)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Bitcoin Trust Etf Common Call Option (IBIT)
Tesla Motors Call Option (TSLA)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Asml Holding N V N Y Registry Shs Call Option (ASML)
Apple Call Option (AAPL)
Astrazeneca Sponsored Adr Call Option
Vaneck Etf Trust Gold Miners Etf Call Option (GDX)
NVIDIA Corporation Call Option (NVDA)
Qualcomm Call Option (QCOM)
Freeport-mcmoran CL B Call Option (FCX)
Spdr Gold Tr Gold Shs (GLD)
Ishares Msci Taiwan Etf (EWT)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)

View all positions for DRW Holdings

Top funds holding Cadrenal Therapeutics

Vanguard Group
DRW Holdings
Citadel Advisors
Geode Capital Management
LPL Financial
Jpmorgan Chase & Co
BlackRock
UBS Group
Tower Research Capital
Advisor Group Holdings
Rockefeller Capital Management
Hartland & Co
Harbour Investments
Wells Fargo & Company
Archer Investment Corp

View all funds holding Cadrenal Therapeutics